3 Year Absolute Returns
34.22% ↑
NAV (₹) on 11 Sep 2026
26.22
1 Day NAV Change
-0.24%
Risk Level
Very High Risk
Rating
-
DSP Healthcare Fund is a Equity mutual fund categorized under Sector, offered by DSP Investment Managers Pvt. Ltd.. Launched on 12 Nov 2018, investors can start with a lumpsum investment of ₹100. The ... Read more
AUM
₹ 3,835.28 Cr
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 67.72% |
| Hospitals & Medical Services | 19.05% |
| Foreign Securities | 8.24% |
| Treps/Reverse Repo | 3.77% |
| Finance - Non Life Insurance | 0.99% |
| International Mutual Fund Units | 0.98% |
| Medical Equipment & Accessories | 0.14% |
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| IPCA Laboratories Limited | 8.74% | ₹ 335.02 | Pharmaceuticals |
| Sun Pharmaceutical Industries Limited | 7.95% | ₹ 304.78 | Pharmaceuticals |
| Sai Life Sciences Limited | 7.45% | ₹ 285.72 | Pharmaceuticals |
| Cipla Limited | 7.35% | ₹ 282.03 | Pharmaceuticals |
| Apollo Hospitals Enterprise Limited | 6.47% | ₹ 248.03 | Hospitals & Medical Services |
| Gland Pharma Limited | 5.98% | ₹ 229.50 | Pharmaceuticals |
| Globus Medical Inc | 5.44% | ₹ 208.77 | Others |
| Divi's Laboratories Limited | 4.15% | ₹ 159.26 | Pharmaceuticals |
| Alkem Laboratories Limited | 4.08% | ₹ 156.61 | Pharmaceuticals |
| Cohance Lifesciences Limited | 3.81% | ₹ 146.04 | Pharmaceuticals |
| TREPS / Reverse Repo Investments | 3.77% | ₹ 144.58 | Others |
| Manipal Health Enterprises Limited | 3.70% | ₹ 141.84 | Hospitals & Medical Services |
| Pfizer Limited | 3.22% | ₹ 123.49 | Pharmaceuticals |
| Alembic Pharmaceuticals Limited | 3.14% | ₹ 120.44 | Pharmaceuticals |
| Kovai Medical Center And Hospital Limited | 2.80% | ₹ 107.41 | Hospitals & Medical Services |
| Concord Biotech Limited | 2.77% | ₹ 106.41 | Pharmaceuticals |
| Vijaya Diagnostic Centre Limited | 2.44% | ₹ 93.49 | Hospitals & Medical Services |
| Procter & Gamble Health Limited | 2.40% | ₹ 91.88 | Pharmaceuticals |
| Thyrocare Technologies Limited | 2.11% | ₹ 81.07 | Hospitals & Medical Services |
| Indoco Remedies Limited | 2.06% | ₹ 78.98 | Pharmaceuticals |
| Intuitive Surgical Inc | 1.76% | ₹ 67.51 | Others |
| Unichem Laboratories Limited | 1.64% | ₹ 62.82 | Pharmaceuticals |
| Syngene International Limited | 1.31% | ₹ 50.08 | Pharmaceuticals |
| Nephrocare Health Services Limited | 1.13% | ₹ 43.37 | Hospitals & Medical Services |
| ICICI Lombard General Insurance Co Limited | 0.99% | ₹ 37.83 | Finance - Non Life Insurance |
| Global X Funds - Global X Genomics & Biotechnology ETF | 0.98% | ₹ 37.66 | Others |
| Aarti Drugs Limited | 0.91% | ₹ 35.08 | Pharmaceuticals |
| Abbott Laboratories | 0.87% | ₹ 33.29 | Others |
| Eris Lifesciences Limited | 0.76% | ₹ 29.30 | Pharmaceuticals |
| Jupiter Life Line Hospitals Limited | 0.40% | ₹ 15.27 | Hospitals & Medical Services |
| Grail Inc | 0.17% | ₹ 6.62 | Others |
| Laxmi Dental Limited | 0.14% | ₹ 5.48 | Medical Equipment & Accessories |
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 5.56% | 4.73% | -2.88% | 10.31% |
| Category returns | 3.34% | 3.85% | 2.63% | 19.22% |
The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹35.68 | 112.59% | 288.37% | 0.00% | ₹1,128 | 1.12% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹35.68 | 112.59% | 288.37% | 0.00% | ₹1,128 | 1.12% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹35.68 | 112.59% | 288.37% | 0.00% | ₹1,128 | 1.12% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹33.31 | 109.75% | 272.68% | 0.00% | ₹1,128 | 2.40% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹33.31 | 109.75% | 272.68% | 0.00% | ₹1,128 | 2.40% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹33.31 | 109.75% | 272.68% | 0.00% | ₹1,128 | 2.40% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.08 | 19.59% | 150.97% | 0.00% | ₹11,478 | 0.89% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.08 | 19.59% | 150.97% | 0.00% | ₹11,478 | 0.89% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.08 | 19.59% | 150.97% | 0.00% | ₹11,478 | 0.89% |
Very High
|
|
HDFC Defence Fund
Sector
Regular
|
₹29 | 18.43% | 142.90% | 0.00% | ₹11,478 | 1.78% |
Very High
|
What is the current NAV of DSP Healthcare Fund Regular IDCW-Reinvestment?
What is the fund size (AUM) of DSP Healthcare Fund Regular IDCW-Reinvestment?
What are the historical returns of DSP Healthcare Fund Regular IDCW-Reinvestment?
What is the risk level of DSP Healthcare Fund Regular IDCW-Reinvestment?
What is the minimum investment amount for DSP Healthcare Fund Regular IDCW-Reinvestment?
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article